FDA Panel Rejects Mirabel’s Bioimpedance Device For Breast Scanning
This article was originally published in The Gray Sheet
Executive Summary
FDA's Obstetrics & Gynecology Devices Panel voted unanimously not to recommend approval of Mirabel Medical Systems' T-Scan 2000 ED bioimpedance device at an Aug. 29 meeting in Gaithersburg, Md